CADI-R404

CADI-R404 is a proprietary biological model developed by Bio-Modeling Systems (BMSystems) using their Computer Assisted Deductive Integration (CADI) platform. This model is specifically designed to map the complex biological pathways involved in metabolism and metabolic syndrome. By integrating multi-omics data and scientific literature, CADI-R404 identifies novel therapeutic targets and biomarkers, particularly those related to mitochondrial energy metabolism and epigenetic regulation. It serves as the foundational research for the company's metabolic therapeutic pipeline, including the CADI-T4031 program, which is currently in preclinical development for metabolic syndrome. The model aims to elucidate the genetic and epigenetic mechanisms that drive metabolic dysfunction to enable the development of targeted therapeutic protocols.